Your mileage may vary
Defining the quality of hematopoietic stem cell products: the devil is in the details
Hemoglobin C after a red blood cell transfusion for sickle cell disease
Continuing Medical Education Program in Transfusion
How we approach a patient with symptoms of leukostasis requiring emergent leukocytapheresis
Cost implications of implementation of pathogen-inactivated platelets
Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasma
Blood transfusion and 30-day readmission rate in adult patients hospitalized with sickle cell disease crisis
Quality of the hematopoietic stem cell graft affects the clinical outcome of allogeneic stem cell transplantation
Plerixafor in combination with granulocyte–colony-stimulating factor after chemotherapy increases mobilization efficiency in patients with lymphoma or myeloma: results of a Phase II clinical trial
Blood graft cellular composition and posttransplant recovery in non-Hodgkin's lymphoma patients mobilized with or without plerixafor: a prospective comparison
Red blood cell antigen genotype analysis for 9087 Asian, Asian American, and Native American blood donors
Sequencing of the ART4 gene in sub-Saharan cohorts reveals ethnic differences and two new DO alleles: DO*B-Ile5Thr and DO*B-Trp266Arg
Fatal false-negative transfusion infection involving a buffy coat platelet pool contaminated with biofilm-positive Staphylococcus epidermidis : a case report
Evaluation of efficacy of prion reduction filters using blood from an endogenously infected 263K scrapie hamster model
Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab
Ultraviolet C light pathogen inactivation treatment of platelet concentrates preserves integrin activation but affects thrombus formation kinetics on collagen in vitro
Quality of red blood cells washed using a second wash sequence on an automated cell processor
Cryopreservation alters the membrane and cytoskeletal protein profile of platelet microparticles
Nanofiltration to remove microparticles and decrease the thrombogenicity of plasma: in vitro feasibility assessment
Type of plasma preparation used for plasma exchange and clinical outcome of adult patients with acquired idiopathic thrombotic thrombocytopenic purpura: a French retrospective multicenter cohort study
Renitrosylation of banked human red blood cells improves deformability and reduces adhesivity
Effects of nitric oxide and its congeners on sickle red blood cell deformability
Handling low hemoglobin and iron deficiency in a blood donor population: 2 years' experience
Blood donation and blood donor mortality after adjustment for a healthy donor effect
Acute hemolytic transfusion reaction due to anti-Leb
Sensitivity of hepatitis C virus core antigen and antibody combination assays in a global panel of window period samples
Bimodal distribution of Trypanosoma cruzi antibody levels in blood donors from a highly endemic area of Argentina: what is the significance of low-reactive samples?
Romiplostim in the management of the thrombocytopenic surgical patient
Serial ADAMTS13 measurements during initial plasma exchange therapy guide decisions for management of unresponsive thrombotic thrombocytopenic purpura
Thrombotic thrombocytopenic purpura during pregnancy versus imitator of preeclampsia
RHCE*cE94G encodes variable expression of c (RH4)
Novel RHAG allele encoding the Rhnull phenotype in Brazil
Blood donation in China: sustaining efforts and challenges in achieving safety and availability
Incident hepatitis among repeat blood donors: A sentinel event signaling possible health care–associated infection and need for reporting to public health authorities